If an eligible patient dies while being treated with an investigational drug, biological product, or device, the patient's heirs are not liable for any outstanding debt related to the treatment or to a lack of insurance as a result of the treatment.
KRS 217.5406
Death of patient receiving experimental treatment absolves heirs of liability for resulting debt
Effective: June 29, 2017 History: Created 2017 Ky
Official source: Kentucky General Assembly. Reproduced from public-domain Kentucky statutes; confirm against the official source for the current text. Not legal advice.